Table 2 Pharmacokinetics of DOACs
From: An update on applications and limitations of direct oral anticoagulants
Drug | Half life | Time to elapse 5 half lives |
|---|---|---|
Apixaban | 8–15 h | 1.5–3 days after last dose |
Rivaroxaban | 5–9 h | 1–2 days after last dose |
Edoxaban | 6–11 h | 1.3–2 days after last dose |
Dabigatran | 12–17 h | 2.5–3.5 days after last dose |